Cargando…

Estimation of Health State Utility Values in Fabry Disease Using Vignette Development and Valuation

Background: Health state utilities are measures of health-related quality of life that reflect the value placed on improvements in patients’ health status and are necessary for estimation of quality-adjusted life-years. Health state utility data on Fabry disease (FD) are limited. In this study we us...

Descripción completa

Detalles Bibliográficos
Autores principales: Hughes, Derralynn, Lenny, Andrew, Shah, Koonal, Longworth, Louise, Devercelli, Giovanna, Ayodele, Olulade
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Columbia Data Analytics, LLC 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095067/
https://www.ncbi.nlm.nih.gov/pubmed/37064293
http://dx.doi.org/10.36469/001c.71344
_version_ 1785023992621432832
author Hughes, Derralynn
Lenny, Andrew
Shah, Koonal
Longworth, Louise
Devercelli, Giovanna
Ayodele, Olulade
author_facet Hughes, Derralynn
Lenny, Andrew
Shah, Koonal
Longworth, Louise
Devercelli, Giovanna
Ayodele, Olulade
author_sort Hughes, Derralynn
collection PubMed
description Background: Health state utilities are measures of health-related quality of life that reflect the value placed on improvements in patients’ health status and are necessary for estimation of quality-adjusted life-years. Health state utility data on Fabry disease (FD) are limited. In this study we used vignette (scenario) construction and valuation to develop health state utilities. Objectives: The aim of this study was to use vignette construction and valuation to estimate health state utility values suitable for inclusion in economic models of FD treatments. Methods: Health state vignettes were developed from semistructured qualitative telephone interviews with patients with FD and informed by published literature and input from an expert. Each vignette was valued in an online survey by members of the United Kingdom (UK) general population using the composite time trade-off (TTO) method, which aims to determine the time the respondent would trade to live in full health compared with each impaired health state. Results: Eight adults (50% women) with FD from the UK were interviewed. They were recruited via various approaches, including patient organizations and social media. The interviewees’ responses, evidence from published literature, and input from a clinical expert informed the development of 6 health state vignettes (pain, moderate clinically evident FD [CEFD], severe CEFD, end-stage renal disease [ESRD], stroke, and cardiovascular disease [CVD]) and 3 combined health states (severe CEFD + ESRD, severe CEFD + CVD, and severe CEFD + stroke). A vignette valuation survey was administered to 1222 participants from the UK general population who were members of an external surveying organization and agreed to participate in this study; 1175 surveys were successfully completed and included in the analysis. Responses to TTO questions were converted into utility values for each health state. Pain was the highest valued health state (0.465), and severe CEFD + ESRD was the lowest (0.033). Discussion: Overall, mean utility values declined as the severity of the vignettes increased, indicating that respondents were more willing to trade life-years to avoid a severe health state. Conclusions: Health state vignettes reflect the effects of FD on all major health-related quality-of-life domains and may help to support economic modeling for treatment of FD.
format Online
Article
Text
id pubmed-10095067
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Columbia Data Analytics, LLC
record_format MEDLINE/PubMed
spelling pubmed-100950672023-04-13 Estimation of Health State Utility Values in Fabry Disease Using Vignette Development and Valuation Hughes, Derralynn Lenny, Andrew Shah, Koonal Longworth, Louise Devercelli, Giovanna Ayodele, Olulade J Health Econ Outcomes Res Hereditary Genetic Disorders Background: Health state utilities are measures of health-related quality of life that reflect the value placed on improvements in patients’ health status and are necessary for estimation of quality-adjusted life-years. Health state utility data on Fabry disease (FD) are limited. In this study we used vignette (scenario) construction and valuation to develop health state utilities. Objectives: The aim of this study was to use vignette construction and valuation to estimate health state utility values suitable for inclusion in economic models of FD treatments. Methods: Health state vignettes were developed from semistructured qualitative telephone interviews with patients with FD and informed by published literature and input from an expert. Each vignette was valued in an online survey by members of the United Kingdom (UK) general population using the composite time trade-off (TTO) method, which aims to determine the time the respondent would trade to live in full health compared with each impaired health state. Results: Eight adults (50% women) with FD from the UK were interviewed. They were recruited via various approaches, including patient organizations and social media. The interviewees’ responses, evidence from published literature, and input from a clinical expert informed the development of 6 health state vignettes (pain, moderate clinically evident FD [CEFD], severe CEFD, end-stage renal disease [ESRD], stroke, and cardiovascular disease [CVD]) and 3 combined health states (severe CEFD + ESRD, severe CEFD + CVD, and severe CEFD + stroke). A vignette valuation survey was administered to 1222 participants from the UK general population who were members of an external surveying organization and agreed to participate in this study; 1175 surveys were successfully completed and included in the analysis. Responses to TTO questions were converted into utility values for each health state. Pain was the highest valued health state (0.465), and severe CEFD + ESRD was the lowest (0.033). Discussion: Overall, mean utility values declined as the severity of the vignettes increased, indicating that respondents were more willing to trade life-years to avoid a severe health state. Conclusions: Health state vignettes reflect the effects of FD on all major health-related quality-of-life domains and may help to support economic modeling for treatment of FD. Columbia Data Analytics, LLC 2023-04-10 /pmc/articles/PMC10095067/ /pubmed/37064293 http://dx.doi.org/10.36469/001c.71344 Text en https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (4.0) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Hereditary Genetic Disorders
Hughes, Derralynn
Lenny, Andrew
Shah, Koonal
Longworth, Louise
Devercelli, Giovanna
Ayodele, Olulade
Estimation of Health State Utility Values in Fabry Disease Using Vignette Development and Valuation
title Estimation of Health State Utility Values in Fabry Disease Using Vignette Development and Valuation
title_full Estimation of Health State Utility Values in Fabry Disease Using Vignette Development and Valuation
title_fullStr Estimation of Health State Utility Values in Fabry Disease Using Vignette Development and Valuation
title_full_unstemmed Estimation of Health State Utility Values in Fabry Disease Using Vignette Development and Valuation
title_short Estimation of Health State Utility Values in Fabry Disease Using Vignette Development and Valuation
title_sort estimation of health state utility values in fabry disease using vignette development and valuation
topic Hereditary Genetic Disorders
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095067/
https://www.ncbi.nlm.nih.gov/pubmed/37064293
http://dx.doi.org/10.36469/001c.71344
work_keys_str_mv AT hughesderralynn estimationofhealthstateutilityvaluesinfabrydiseaseusingvignettedevelopmentandvaluation
AT lennyandrew estimationofhealthstateutilityvaluesinfabrydiseaseusingvignettedevelopmentandvaluation
AT shahkoonal estimationofhealthstateutilityvaluesinfabrydiseaseusingvignettedevelopmentandvaluation
AT longworthlouise estimationofhealthstateutilityvaluesinfabrydiseaseusingvignettedevelopmentandvaluation
AT devercelligiovanna estimationofhealthstateutilityvaluesinfabrydiseaseusingvignettedevelopmentandvaluation
AT ayodeleolulade estimationofhealthstateutilityvaluesinfabrydiseaseusingvignettedevelopmentandvaluation